PhaseBio Pharmaceuticals, Inc. (PHASQ)

OTCMKTS: PHASQ · Delayed Price · USD

0.0000

0.00 (0.00%)

May 15, 2024, 10:52 AM EDT - Market closed

PhaseBio Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017	2016
Net Income	-0.13	-98.57	-39.25	-23.85	-10.25	Upgrade
Depreciation & Amortization	1.79	0.51	0.17	0.11	0.1	Upgrade
Share-Based Compensation	2.27	2.24	1.42	0.33	0.08	Upgrade
Other Operating Activities	-51.35	35.86	-1.94	6.36	1.82	Upgrade
Operating Cash Flow	-47.42	-59.96	-39.59	-17.05	-8.26	Upgrade
Capital Expenditures	-2.68	-1.41	-0.96	-0.12	-0.22	Upgrade
Investing Cash Flow	-2.68	-1.41	-0.96	-0.12	-0.22	Upgrade
Common Stock Issued	60.35	2.94	46.28	42.97	0	Upgrade
Other Financing Activities	3.42	12.52	7.25	21.82	18.17	Upgrade
Financing Cash Flow	63.77	15.47	53.53	64.8	18.17	Upgrade
Net Cash Flow	13.68	-45.9	12.97	47.63	9.69	Upgrade
Free Cash Flow	-50.1	-61.37	-40.55	-17.17	-8.48	Upgrade
Free Cash Flow Margin	-462515.00%	-19177.81%	-1717.66%	-2570.66%	-	Upgrade
Free Cash Flow Per Share	-1.70	-2.11	-1.48	-3.24	-0.75	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.